| Sanofi-Aventis (Suisse) SA - Mutagrip, Suspension zur Injektion | | 00373 | | 18 | | Mutagrip | | Suspension zur Injektion | | J07BB02 | | Influenza, gereinigtes Antigen | | 21.08.2009 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) A/Brisbane/59/2007 - like A/Brisbane/59/2007 (IVR-148) 15 µg, haemagglutininum influenzae A (H3N3) A/Brisbane/10/2007 -like strain used (A/Uruguay716/2007 (NYMC X-175C) 15 µg, haemagglutininum influenzae B B/Brisbane 60/2008 - like strain: B/Brisbane/60/2008 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residui: formaldehydum, octoxinolum-9, saccharum, neomycinum, ovalbuminum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension zur Injektion | | | |
| Principe actif |
|---|
| Vaccinum Influenzae-Split, Inactivatum 2018/2019 |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 017 | 0.5 ml | 8.51 | 17.95 | B | | Oui |
|
|
